Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Provider-initiated HIV testing uptake and socio-economic status among women in a conflict zone in the Central African Republic: a mixed-methods cross-sectional study. | Confl Health | 2023 | 36973827 | PubTator, text mining | PubMed |
| Ebanga™: The most recent FDA-approved drug for treating Ebola. | Front Pharmacol | 2023 | 36969842 | PubTator, text mining | PubMed |
| Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study. | Taiwan J Obstet Gynecol | 2023 | 36965901 | PubTator, text mining | PubMed |
| Viral- and tumor-reactive natural killer cells. | Semin Immunol | 2023 | 36965383 | PubTator, text mining | PubMed |
| Pathogenesis of allergic diseases and implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36964157 | PubTator, text mining | PubMed |
| Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature. | Front Oncol | 2023 | 36959812 | PubTator, text mining | PubMed |
| Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma. | Oncologist | 2023 | 36952231 | PubTator, text mining | PubMed |
| Transmission of Zika virus by dendritic cell subsets in skin and vaginal mucosa. | Front Immunol | 2023 | 36949942 | PubTator, text mining | PubMed |
| Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. | Front Oncol | 2023 | 36937406 | PubTator, text mining | PubMed |
| Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling. | Diagnostics (Basel) | 2023 | 36900088 | PubTator, text mining | PubMed |
| Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 36893885 | PubTator, text mining | PubMed |
| Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma. | Front Pharmacol | 2023 | 36891274 | PubTator, text mining | PubMed |
| Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. | Ther Adv Med Oncol | 2023 | 36872946 | PubTator, text mining | PubMed |
| Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions. | Pharmacol Ther | 2023 | 36871784 | PubTator, text mining | PubMed |
| Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer. | Clin Pharmacokinet | 2023 | 36869986 | PubTator, text mining | PubMed |
| Repurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection. | Antimicrob Agents Chemother | 2023 | 36853000 | PubTator, text mining | PubMed |
| Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. | Viruses | 2023 | 36851782 | PubTator, text mining | PubMed |
| Molecular and functional imaging in cancer-targeted therapy: current applications and future directions. | Signal Transduct Target Ther | 2023 | 36849435 | PubTator, text mining | PubMed |
| You are what you eat and how you digest it! A discussion on inflammatory efferocytosis. | Front Cell Dev Biol | 2023 | 36846584 | PubTator, text mining | PubMed |
| Ferroptosis-related lncRNA model based on CFAP58-DT for predicting prognosis and immunocytes infiltration in endometrial cancer. | Ann Transl Med | 2023 | 36846008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=22